封面
市场调查报告书
商品编码
2008181

鸭用药品和疫苗市场:按类型、应用和地区划分

Duck Medicine and Vaccines Market, By Type (Medicine, Vaccines), By Application (Farm, Government), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到2026年,鸭药和疫苗市场规模将达到25.6亿美元,到2033年将达到42.65亿美元。预计从2026年到2033年,该市场将以7.6%的复合年增长率成长。

分析范围 分析详情
基准年 2025 市场规模(2026 年) 25.6亿美元
效能数据 2020-2024 预测期 2026-2033
预测期(2026-2033 年)复合年增长率 7.60% 预计金额(2033 年) 42.65亿美元

养鸭业在世界成长最快的产业之一——家禽业中扮演着至关重要的角色。鸭病是一个主要问题,因为它们会影响小规模和无地养殖户的经济收入。鸭子是农村生计的重要组成部分,因为它们能提供稳定的肉蛋供应。预防疫情爆发最重要的措施之一是保持鸭子的健康。与其他影响鸭子的疾病相比,病毒已被报告对鸭子的生产力造成毁灭性的影响。鸭子中最常见的疾病是大肠桿菌感染疾病,这通常是由于养殖场卫生条件不佳造成的。鸭子对霉菌毒素,尤其是黄曲毒素,极为敏感。黄曲毒素是一种由黄曲菌产生的有毒致癌性代谢物,主要损害肝臟。这是一个根深蒂固却常常被忽略的问题。毒素吸附剂,即添加到家禽饲料中以微量存在的物质,用于中和或灭活有害化学物质、霉菌毒素或内毒素,应定期添加到鸭饲料中。适当的疫苗接种和治疗有助于预防鸭子疾病。

市场动态

预计科学家加强对鸭病疫苗的研发力度将推动预测期内市场成长。例如,2020年9月,喀拉拉邦兽医与动物科学大学(KVASU)曼努蒂分校兽医微生物学系的科学家们研发出一种针对鸭类致病性线虫病(一种导致鸭类大量死亡的细菌性疾病)的疫苗。该大学致力于推广永续且盈利的畜牧养殖系统。线虫病在鸭类的死亡率为5%至75%,在5週龄以下的雏鸭中死亡率超过50%。

本报告的主要特点

  • 本报告指出了各个细分市场的潜在商机,并描述了该市场中一系列有吸引力的投资提案。
  • 此外,它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本节根据以下参数介绍全球鸭药和疫苗市场的主要企业概况:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
  • 《全球鸭药和疫苗市场》报告面向该行业的众多相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过分析全球鸭药和疫苗市场中使用的各种策略矩阵来促进决策。

目录

第一章:分析目标与假设

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章:市场动态、监管与趋势分析

  • 市场动态
  • 促进因素
  • 抑制因子
  • 市场机会
  • 影响分析
  • 市场趋势
  • 监管趋势
  • 救赎方案
  • 科技趋势
  • 新产品发布
  • PEST分析

第四章:全球鸭药和疫苗市场:按类型划分(2020-2033 年)

  • 概述
  • 製药
  • 疫苗

第五章:全球鸭药和疫苗市场:按应用领域划分(2020-2033 年)

  • 概述
  • 水产养殖
  • 政府

第六章:全球鸭药及疫苗市场:依地区划分(2020-2033年)

  • 北美洲
    • 我们
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 其他亚太地区
  • 中东
    • GCC
    • 以色列
    • 其他中东国家
  • 非洲
    • 北非
    • 中非
    • 南非

第七章 竞争情势

  • Boehringer Ingelheim International GmbH.
  • Ceva
  • YEBIO BIOENGINEERING CO., LTD
  • NAVETCO
  • Shangqiu Meilan Biological Engineering Co.,Ltd
  • Merck & Co., Inc.
  • EGAVET
  • Bioveta, as
  • Jilin Zhengye Biological Products company limited
  • Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.

第八章

  • 分析方法
  • 关于 Coherent Market Insights
简介目录
Product Code: CMI4956

Duck Medicine And Vaccines Market is estimated to be valued at USD 2,560 Mn in 2026 and is expected to reach USD 4,265 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2,560 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.60% 2033 Value Projection: USD 4,265 Mn

Duck farming plays a vital role in the poultry industry, which is one of the fastest-growing sectors in the world. Duck diseases are a major cause of concern because they can affect finances of small and landless farmers. Ducks are important to rural livelihoods because they provide a steady supply of meat and eggs. One of the most important measures to prevent outbreaks is to maintain the health of the ducks. Viruses have been reported to have more devastating consequences for duck productivity than other diseases that affect ducks. The most prevalent disease in ducks is Escherichia coli due to poor farm hygiene. Ducks are highly vulnerable to mycotoxins, notably aflatoxin, a toxic and carcinogenic metabolite of Aspergillus flavus that primarily affects the liver. This is a persistent issue that isn't always recognized. A toxin binder, which is a substance added to poultry feed in minute quantities to neutralize or immobilize harmful chemicals, mycotoxins or endotoxins should be included in duck diets on a regular basis. Proper vaccination and treatment can help prevent diseases in ducks.

Market Dynamics

The increasing research and development activities by scientists to develop vaccines for the diseases of ducks are expected to drive the market growth during the forecast period. For instance, in September 2020, scientists at the Department of Veterinary Microbiology, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, a university aiming to promote sustainable and profitable animal production systems, developed a vaccine for Riemerellosis, a bacterial disease that causes significant mortality in ducks. In ducks, Riemerellosis causes 5-75 percent mortality and more than 50 percent mortality in ducklings under the age of five weeks.

Key features of the study

  • This report provides an in-depth analysis of the global duck medicine and vaccines market, and provides market size (USD million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global duck medicine and vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Boehringer Ingelheim International GmbH., Ceva, YEBIO BIOENGINEERING CO., LTD., NAVETCO, Shangqiu Meilan Biological Engineering Co.,Ltd., Merck & Co., Inc., EGAVET, Bioveta, a.s., Jilin Zhengye Biological Products company limited, and Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global duck medicine and vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global duck medicine and vaccines market

Market Segmentation

  • By Type Insights (Revenue, USD Mn, 2020 - 2033)
    • Medicine
    • Vaccines
  • By Application Insights (Revenue, USD Mn, 2020 - 2033)
    • Farm
    • Government
  • By Region Insights (Revenue, USD Mn, 2020 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • Boehringer Ingelheim International GmbH
    • Ceva
    • YEBIO BIOENGINEERING CO., LTD.
    • NAVETCO
    • Shangqiu Meilan Biological Engineering Co. Ltd.
    • Merck & Co., Inc.
    • EGAVET
    • Bioveta, a.s.
    • Jilin Zhengye Biological Products company limited
    • Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Regulatory Scenario
  • Reimbursement Scenario
  • Technology Landscape
  • Product Launches
  • PEST Analysis

4. Global Duck Medicine and Vaccines Market, By Type, 2020 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2020 and 2033 (%)
    • Y-o-Y Growth Analysis, 2020 - 2033
    • Segment Trends
  • Medicine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
  • Vaccines
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)

5. Global Duck Medicine and Vaccines Market, By Application, 2020 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2020 and 2033 (%)
    • Y-o-Y Growth Analysis, 2020 - 2033
    • Segment Trends
  • Farm
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Government
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Duck Medicine and Vaccines Market, By Region, 2020 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2020-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
      • UK
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Boehringer Ingelheim International GmbH.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ceva
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • YEBIO BIOENGINEERING CO., LTD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NAVETCO
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Shangqiu Meilan Biological Engineering Co.,Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • EGAVET
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bioveta, a.s.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Jilin Zhengye Biological Products company limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

8. Section

  • Research Methodology
  • About Us